A Study of Effect of Megakaryocytes and Platelets in Breast Cancer

NCT06011824 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2025-05-02

No results posted yet for this study

Summary

Determining if Megakaryocytes and Platelets are Harmful or Helpful in Breast Cancer Cell Metastasis

Conditions

Interventions

OTHER

Blood draw

10-12mL of blood will be drawn one time, unless a redraw is needed, in which case up to 24 mL will be drawn (10-12 mL each draw)

Sponsors & Collaborators

Principal Investigators

  • Scott H. Okuno, M.D. · Mayo Clinic Health System-Franciscan Healthcare

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-29
Primary Completion
2025-04-29
Completion
2025-04-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06011824 on ClinicalTrials.gov